Differential Day-Night Outcome to HSV-2 Cutaneous Infection

J Invest Dermatol. 2018 Jan;138(1):233-236. doi: 10.1016/j.jid.2017.07.838. Epub 2017 Aug 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / pharmacology
  • Acyclovir / therapeutic use
  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Circadian Clocks / physiology*
  • DNA-Binding Proteins / genetics
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Herpes Simplex / mortality
  • Herpes Simplex / physiopathology*
  • Herpes Simplex / prevention & control
  • Herpes Simplex / virology
  • Herpesvirus 2, Human / isolation & purification
  • Herpesvirus 2, Human / pathogenicity*
  • Host Microbial Interactions / physiology*
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nectins / metabolism
  • Severity of Illness Index
  • Skin / metabolism
  • Skin / virology
  • Survival Rate
  • Treatment Outcome

Substances

  • Antiviral Agents
  • DNA-Binding Proteins
  • Nectin1 protein, mouse
  • Nectins
  • Rag2 protein, mouse
  • Acyclovir